Proctitis after brachytherapy for rectal cancer: clinical and dosimetric factors - The HERBERT study

被引:0
|
作者
Rijkmans, E. C. [1 ]
Nout, R. A. [1 ]
Kerkhof, E. M. [1 ]
Cats, A. [2 ]
Van Triest, B. [3 ]
Inderson, A. [4 ]
Van den Ende, R. P. J. [1 ]
Laman, M. S. [1 ]
Ketelaars, M. [1 ]
Marijnen, C. A. M. [1 ]
机构
[1] LUMC, Dept Radiotherapy, Leiden, Netherlands
[2] Netherlands Canc Inst, Dept Gastroenterol, Amsterdam, Netherlands
[3] Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands
[4] LUMC, Dept Gastroenterol, Leiden, Netherlands
关键词
D O I
10.1016/S0167-8140(18)30590-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OC-0280
引用
收藏
页码:S143 / S144
页数:2
相关论文
共 50 条
  • [31] Risk factors of chronic radiation proctitis after radiotherapy for cervical cancer
    Yiu, Mulia
    Supriana, Nana
    Abdulah, Murdani
    Makmun, Dadang
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 561 - 561
  • [32] Prediction models for rectal toxicity after brachytherapy in patients with pelvic cancer
    Tohidinezhad, F.
    Willems, Y.
    Berbee, M.
    Van Limbergen, E.
    Verhaegen, F.
    Dekker, A.
    Traverso, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S565 - S566
  • [33] Rectal bleeding after hypofractionated radiotherapy for prostate cancer: Correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding
    Akimoto, T
    Muramatsu, H
    Takahashi, M
    Saito, J
    Kitamoto, Y
    Harashima, K
    Miyazawa, Y
    Yamada, M
    Ito, K
    Kurokawa, K
    Yamanaka, H
    Nakano, T
    Mitsuhashi, N
    Niibe, H
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (04): : 1033 - 1039
  • [34] Prostatourethral-rectal fistula after prostate brachytherapy - Incidence and risk factors
    Theodorescu, D
    Gillenwater, JY
    Koutrouvelis, PG
    [J]. CANCER, 2000, 89 (10) : 2085 - 2091
  • [35] Incidence and dosimetric predictive factors of late rectal toxicity after low-dose-rate brachytherapy combined with volumetric modulated arc therapy in high-risk prostate cancer at a single institution: Retrospective study
    Sakurai, Takayuki
    Takamatsu, Shigeyuki
    Shibata, Satoshi
    Taka, Masashi
    Ishiyama, Mizuho
    Yamazaki, Masahiro
    Kojima, Hironori
    Mizokami, Atsushi
    Kumano, Tomoyasu
    Gabata, Toshifumi
    [J]. BRACHYTHERAPY, 2021, 20 (03) : 584 - 594
  • [36] A dosimetric analysis of the rectal doses in intracavitary brachytherapy of carcinoma cervix: A prospective study from a single institute
    Suryadevara, Aparna
    Talluri, And Kumar
    Alluri, Krishnam Raju
    Vasundhara, E.
    Kumar, Sudhakar
    Sresty, N. V. N. Madhusudhana
    [J]. JOURNAL OF MEDICAL PHYSICS, 2019, 44 (04) : 287 - 291
  • [37] Study on Dosimetric Benefits of Adaptive Brachytherapy in the Treatment of Postoperative Cervical Cancer Patients
    Jiang, C.
    Wei, Q.
    Wang, X.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E735 - E735
  • [38] Improved understanding of subtle rectal toxicity after prostate brachytherapy: Results with a comprehensive toxicity scoring system and identification of rectal dosimetric toxicity predictors
    Shah, JN
    Ennis, RD
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S316 - S317
  • [39] Clinical and dosimetric correlation in terms of treatment response, bladder and rectal toxicities in cervical cancer patients treated with cobalt 60 high dose rate brachytherapy
    Makkapati, Bharat Sai
    Challapalli, Srinivas
    Senthiappan, Athiyamaan Mariappan
    Kilikunnel, Johan Sunny
    Krishna, Abhishek
    Lobo, Dilson
    Jawahar, Vaishak
    Banerjee, Sourjya
    [J]. PEERJ, 2024, 12
  • [40] IMPORTANCE OF INCLUDING CLINICAL FACTORS IN RECTAL NTCP MODELING AFTER RADIOTHERAPY FOR PROSTATE CANCER
    Defraene, G.
    Van den Bergh, L.
    Al-Mamgani, A.
    Haustermans, K.
    Heemsbergen, W.
    Van den Heuvel, F.
    Lebesque, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S127 - S127